Building the Strategic Communications Roadmap
Donna L. LaVoiePresident & CEO, LaVoieHealthScience
2019 Communications ObjectivesExample
2
1. Build visibility in the local biotechnology ecosystem, general biotechnology industry, and gene therapy community through earned media coverage
2. Support publicity initiatives surrounding key conferences and collaborations
3. Ramp up volume of original content, further establishing thought-leadership through blog topics and industry insights as well as leveraging social media to amplify reach
4. Start pre-IPO planning—what we need to do to start looking like a public company
Investors
Business & Partnership
Opportunities
Patients/Advocacy
Physicians/KOLs
Government & Regulatory Agencies
Health & Life Science Industry
Conference Support
4
• Strategic Counsel
• Message Development
• External Relations
– Meeting making
– Media interviews
– Partnering portal support
– Panel opportunities and keynotes
– Onsite support TBD
– Investor and business development introductions
• Other Conferences to Consider
– Medical Congresses• Gene Therapy for Rare Disorders, Boston, 3/26-28
• The Cell & Gene Meeting on the Mediterranean,
Barcelona, 4/29-5/2
• Neurodegenerative Drug Development –
Focus on Gene Therapy, Parish, 5/21-23
• Annual Conference of the British Society for
Gene and Cell Therapy, Sheffield, 6/25-26
• Cell & Gene Therapy Manufacturing and
Commercialization, Boston, 9/10-13
• CAR-TCR Summit, Boston, 10/9
• Cell & Gene Therapy Strategy Meeting Europe,
Zurich, 10/21-25
– Partnering/Investor Conferences• World Orphan Drug Congress, Maryland, 4/10-4/12
• BioCentury Future Leaders, New York, 4/12
• BioTrinity - European Biopartnering and Investment
Conference 2019, London, 4/30-5/1
• Bio€quity Europe 2019, Barcelona, 5/20-21
• BioCentury Newsmakers, New York, 9/1
• BIO Investor Forum, San Francisco, 10/22-23
• BIO CEO & Investor Conference, New York, 2/10-11
Expanding Your Investor Base:
LHS ReachTM
Paul SaganAVP, Investor Relations & Corporate Communications, LaVoieHealthScience
6
LHS Reach™ Methodology
Engaging with Investors & Partners
Mark MonanePrincipal & Chief Medical Officer Monane Clinical Consulting, LLC
8
Monane Group Clinical Consulting, LLC
Company management teams say the darnest things….
• Things we like to hear from management teams…• References to previous presentations/decks
• Limitations of study design and approach
• Comments from team members other than the CEO
• Things we don’t like to hear…• “We’re under the radar…”
• “We are thinking about …”
• “You love company X, so you cannot like us…”
Building Value:
Managing Media & Social Media
Angus McQuilkenBusiness Development Manager, Life SciencesMcDermott, Will & Emory
Sharon CorreiaSenior Vice President, Integrated Communications
LaVoieHealthScience
BIO International 2019Building the Strategic RoadmapHow Can Brand
Exposure Impact
Investor
Sentiment?
BIO International 2019Building the Strategic Roadmap
What’s News and What’s
Not - Recent Headlines